canadian vte audit - information call
DESCRIPTION
Objective Safer Healthcare Now!, a program of the Canadian Patient Safety Institute, invites you to participate in the Canadian VTE Audit, designed to establish a national perspective of VTE thromboprophylaxis rates and raise awareness of appropriate VTE prophylaxis. VTE is one of the most common and preventable complications of hospitalization and is a Required Organizational Practice (ROP) of Accreditation Canada. By participating in the national audit day you will be a part of a movement aimed at preventing deep vein thrombosis (DVT) and pulmonary embolism (PE) in hospital patients. Watch the recording: http://bit.ly/1wfinCETRANSCRIPT
![Page 1: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/1.jpg)
NATIONAL VTE AUDIT CALL TO ACTION
SEPTEMBER 10, 2014 Artemis Diamantouros, Bill Geerts & Virginia Flintoft
Gina Peck, Anne MacLaurin and Alex Titeu
![Page 2: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/2.jpg)
Please note your phone will be muted when you join the call
• Thank you for joining us. Nous vous remercions de
votre participation.
• Your line will be muted until the call begins.
Les lignes seront sous-silence au début de cet appel.
![Page 3: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/3.jpg)
If there is NO audio: S’il n’y a pas d’ audio de WebEx
1. Click the audio Icon. / Cliquer sur l’icône audio.
2. A popup will display the phone information./ Une boîte de dialogue offre l’information téléphonique
Direct Line Enter
number
Ligne directe, entrer votre
numéro
Line with Extension
“ I will call in”
Ligne avec
poste
Or/ou
964 667 095#
#
3.
![Page 4: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/4.jpg)
Interacting in WebEx: Today’s Tools Interagir dans WebEx: les outils d'aujourd'hui
Please use the chat to ask questions during the presentation, or raise hand when we pause for questions.
![Page 5: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/5.jpg)
• Why participate in the VTE audit?
• What did we learn last year?
• How to complete the audit
• Instructions for getting and using your Data Collection Form
Agenda
![Page 6: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/6.jpg)
Why participate in the VTE audit?
What did we learn last year?
How to complete the audit
Instructions for getting your Data Collection Form
Agenda
![Page 7: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/7.jpg)
Bill Geerts, MD, FRCPC
Thromboembolism Specialist, Sunnybrook Health Sciences Centre
Professor of Medicine, University of Toronto
National lead, VTE Prevention, Safer Healthcare Now!
Why participate in the VTE audit?
![Page 8: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/8.jpg)
Why participate in the VTE audit?
1. Because 60% of all venous thromboembolism (VTE) in the population is hospital-acquired
![Page 9: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/9.jpg)
Burden of Hospital-Acquired VTE
Population of Canada, 2014 35,428,000
Annual VTE rate 35,428
1/1,000/yr
60%
Hospital-acquired VTE rate 21,300/year
![Page 10: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/10.jpg)
Why participate in the VTE audit?
1. Because 60% of all VTE in the population is hospital-acquired
2. Because HA-VTE produces substantial patient harm
![Page 11: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/11.jpg)
Harms of Hospital-Acquired VTE
• Symptomatic DVT, PE • Fatal PE • Prolonged hospital stay (or readmission) • Harm of therapeutic anticoagulation • Patient anxiety • Costs of diagnosis and treatment • Future consequences
![Page 12: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/12.jpg)
Why participate in the VTE audit?
1. Because 60% of all VTE in the population are hospital-acquired
2. Because HA-VTE produces patient harm
3. Because HA-VTE can be prevented (effectively, safely, inexpensively)
![Page 13: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/13.jpg)
Why participate in the VTE audit?
4. Because comprehensive thromboprophylaxis programs are expected by Accreditation Canada and are expected by our PATIENTS
![Page 14: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/14.jpg)
Why participate in the VTE audit?
4. Because comprehensive thromboprophylaxis programs are expected by Accreditation Canada and are expected by our PATIENTS
5. Because it is essential to measure our compliance with this safety standard of care
![Page 15: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/15.jpg)
Thromboprophylaxis improves clinically-important outcomes:
4 examples
Why participate in the VTE audit?
![Page 16: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/16.jpg)
QI improves Thromboprophylaxis 1
Maynard – J Hosp Med 2010;5:10
54% 67% 80% 90% 98%
![Page 17: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/17.jpg)
QI efforts also reduce VTE
Maynard – J Hosp Med 2010;5:10
2005 P
Patients at risk 9,720 11,207
Appropriate prophylaxis 58% 98% <0.001
Hospital-acquired VTE
131 92 <0.001
Preventable hospital-acquired VTE
44 7 <0.001
1
2
![Page 18: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/18.jpg)
Thromboprophylaxis leads to Fewer Adverse Outcomes
Zeidan – Am J Hematol 2013;88:545
2.5%
1.1%
0%
0.5%
1.0%
1.5%
2.0%
2.5%
Symptomatic VTE
Preventable VTE
Clin
ical
Eve
nts a
t 90
days
Major bleeding
0.7%
0% 0.3%
0.1%
Pre-intervention (N=1,000)
Post-intervention (N=942)
• Medical patients at Johns Hopkins
2
![Page 19: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/19.jpg)
• QI project at King’s College Hospital launched in 2010 (aligned with national VTE program)
• Development of a local VTE Prevention Program • Mandatory, documented VTE risk assessment • VTE prophylaxis guidance • Mandatory VTE education • Identification of hospital-associated VTE • Root cause analysis with targeted QI interventions
Effect of a VTE Prevention Program on Hospital-Assoc VTE
Roberts – Chest 2013;144:1276
3
![Page 20: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/20.jpg)
Patients with a VTE Risk Assessment
Roberts – Chest 2013;144:1276
% o
f pat
ient
s
![Page 21: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/21.jpg)
• QI project at King’s College Hospital, London, 2010-12
VTE Prevention Program Reduces Hospital-Associated VTE
2010-11 2011-12 p
VTE risk assessment 63% (38-88) 93% (90-97)
HA-VTE Per 1,000 admissions
236 19.7/mo
1.5
189 15.8/mo
1.0
0.014
Potentially preventable HA-VTE
43%
32%
0.005
Roberts – Chest 2013;144:1276
![Page 22: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/22.jpg)
• All patients admitted to all 163 NHS trusts, 2010-12 • Mandatory reporting of use of the VTE risk tool
Use of the UK National VTE Risk Assessment Tool
Lester – Heart – 2013;99:1734
Rate of VTE risk
assessments performed
[IQR]
100%
0%
50%
July 2010 March 2012
51% [27,71]
93% [91,96]
4
![Page 23: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/23.jpg)
• All 4 million patients admitted to all 163 NHS hospital trusts >3 days, 2010-12
Hospital-Acquired Fatal VTE is Reduced in Adherent Hospitals
Lester – Heart – 2013;99:1734
Fatal VTE <90 days after hospital discharge
Rel Risk for hospitals with VTE risk assessment >90% vs <90%
All 0.85 [0.75-0.96; p=0.01]
Post-discharge 0.81 [0.67-0.79; p=0.03]
Achieving >90% VTE risk assessment is associated with significant lower VTE mortality
![Page 24: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/24.jpg)
National VTE Mortality Data England
Year VTE listed as cause of death
2007 6,121 2008 6,170 2009 6,218 2010 6,282 2011 4,562 2012 4,668
From R. Arya - Office for National Statistics, 2013
![Page 25: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/25.jpg)
• Why participate in the VTE audit?
• What did we learn last year?
• How to complete the audit
• Instructions for getting your Data Collection Form
Agenda
![Page 26: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/26.jpg)
2013 National VTE Audit RESULTS
![Page 27: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/27.jpg)
• Audit April, 2013
• 118 centers, 4,667 patients, 9 provinces coast to coast
• General medical and general surgical patients
• Analyses conducted by CMT with data from Patient Safety Metrics (PS Metrics)
2013 VTE Audit Day
![Page 28: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/28.jpg)
• Overall, thromboprophylaxis use = 81%
- Very good (but with room for improvement)
Thromboprophylaxis Use
![Page 29: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/29.jpg)
Appropriate Thromboprophylaxis - by Province (2013)
% o
f pat
ient
s
100%
65%
![Page 30: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/30.jpg)
Types of Thromboprophylaxis
• Thromboprophylaxis: • LMWH 61% • LMWH or LDH 90% • Mechanical only 4%
• Variability: • By Patient Group:
Medical: LMWH 70% vs LDH 21%
Surgical: LMWH 45% vs LDH 46%
• By province • By region within provinces
![Page 31: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/31.jpg)
• Overall, 19% did not receive appropriate thromboprophylaxis
• Reasons: • No thromboprophylaxis 70% • Delay in start 9% • Wrong dose 8% • Modality varied from SHN recommendation 6%
Reasons for not using Thromboprophylaxis
![Page 32: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/32.jpg)
Reasons for not using Thromboprophylaxis
![Page 33: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/33.jpg)
• Overall, 55% of patients had preprinted order sets
• Huge differences by province (13% 63%) and region
Order set use
![Page 34: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/34.jpg)
Impact of Preprinted Order Sets
N=4,518
Order set used
Order set not used
91%
71%
![Page 35: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/35.jpg)
2014 National VTE Audit
![Page 36: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/36.jpg)
• Why participate in the VTE audit?
• What did we learn last year?
• How to complete the audit
• Instructions for getting your Data Collection Form
Agenda
![Page 37: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/37.jpg)
• When? – October 1 to 15, 2014*
• Purpose: – Obtain a current estimate of national VTE prophylaxis rates – Increase awareness of VTE prophylaxis – Contribute to the first World Thrombosis Day on October
13, 2014 – Improve experience with the VTE Data Collection Tool and
other tools available to support VTE
*Data collected up to Oct. 31st will be accepted
2014 Canadian VTE Audit
![Page 38: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/38.jpg)
• Your commitment: – Approximately 60 minutes
• Your essential contribution: – Helping to improve the delivery of safe and
effective care for patients
Canadian VTE Audit 2014
![Page 39: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/39.jpg)
• The VTE audit will again focus on: – Internal Medicine – General Surgery
• Audit sample can be: – Both Medical AND General Surgical patients
(preferred option) – OR, either Medical or Surgical patients
Patients include
![Page 40: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/40.jpg)
• At least 20 patients from each group (medical, surgical)
• 4 options for determining audit sample: 1. All eligible medical AND general surgical patients 2. All eligible medical OR surgical patients 3. A sample of eligible medical AND surgical patients
(consecutive patients, random sample, 1 or more nursing units)
4. A sample of eligible medical OR a sample of eligible surgical patients
Step 1: Identifying Audit Sample
![Page 41: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/41.jpg)
• Inclusion: – Patients in hospital on Oct. 1 AND with an actual or
expected LOS of more than 2 calendar days – Patients admitted between Oct. 1-15* with an actual or
expected LOS of more than 2 calendar days • Exclusions:
– Patients in hospital >30 calendar days – Patients receiving therapeutic doses of anticoagulants
*May extend to Oct. 31st if required
Eligibility Criteria
![Page 42: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/42.jpg)
• Internal Medicine: – For example, patients admitted with:
• CHF, severe respiratory disease, or confined to bed with active cancer, previous VTE, sepsis, acute neurologic disease, inflammatory bowel disease
• General Surgical Patients: – All general surgical patients are eligible if they meet the
general criteria for eligibility – Exclude Low risk surgical patients
• Non-major surgery and fully mobile and NO additional VTE risk factors
Eligibility Criteria
![Page 43: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/43.jpg)
• Collect data related to 4 questions: 1. Were preprinted orders used on admission or
after surgery? 2. What type of thromboprophylaxis was used? 3. Did the patient receive appropriate
thromboprophylaxis? 4. If no to Q3, why was recommended
thromboprophylaxis not used?
Steps for conducting the audit
![Page 44: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/44.jpg)
• Direct Chart Audit!! – Go to the patient care unit – Determine patient eligibility
• Chart Review/MAR • Report from pharmacy system
– Complete VTE data collection form • More to come . . .
How will you collect the data?
![Page 45: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/45.jpg)
Case 1: No VTE Prophylaxis was ordered – Column 1: answer NO – Column 2: select #12 “No Order” – Column 3: select NO (no appropriate
thromboprophylaxis) – Column 4: select #1 “No Prophylaxis
Ordered”
Reviewing the chart
![Page 46: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/46.jpg)
Case 2: VTE Prophylaxis has been ordered for the patient – Column 1: look at whether an order set was
used to order the VTE prophylaxis • Answer YES or NO in column 1
– Column 2: select the thromboprophylaxis ordered from the list of options
Reviewing the chart
![Page 47: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/47.jpg)
Case 2: VTE Prophylaxis has been ordered for the patient – Column 3: decide whether the VTE
prophylaxis was appropriate for the patient
Reviewing the chart
![Page 48: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/48.jpg)
NB: All patients included in the audit sample are eligible for thromboprophylaxis
• Prophylaxis is considered appropriate if: – It was started within 24 hours (1 calendar day)
of admission or after surgery – Choice is according to evidence-based
anticoagulant prophylaxis – Mechanical thromboprophylaxis if anticoagulant
is contraindicated – patient actively bleeding or at high risk of bleeding)
Determining appropriateness
![Page 49: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/49.jpg)
Case 2: VTE Prophylaxis has been ordered for the patient – Column 4: if you answered NO to column
3, choose the reason(s) why the order was not appropriate
Reviewing the chart
![Page 50: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/50.jpg)
How to participate in the VTE Audit
![Page 51: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/51.jpg)
1. Use your VTE form from last years VTE Audit www.patientsafetymetrics.ca
2. Register for VTE audit day and we will create and email your data collection form http://www.saferhealthcarenow.ca/EN/events/other/VTEAudit/Pages/default.aspx
3. Register for Patient Safety Metrics and create your own Data Collection Tool. www.patientsafetymetrics.ca
Refer to the detailed instructions for more information about each option. http://www.saferhealthcarenow.ca/EN/events/other/VTEAudit/Pages/default.aspx
3 options for getting your form
51
![Page 52: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/52.jpg)
52
How to Request a Data Collection (Audit) Form
![Page 53: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/53.jpg)
Completing Audit Form Request
![Page 54: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/54.jpg)
Patient Safety Metrics An Overview
![Page 55: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/55.jpg)
Features: • Cloud-based data collection and reporting tool • User friendly and simple to navigate • Accessible from website with login details • Tracks >100 process and outcome measures over 14
interventions • Provides real time reporting. • Reduces burden of data collection, entry and analysis • Capacity to customize measures and reports
Patient Safety Metrics
![Page 56: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/56.jpg)
• Data Collection Forms – Patient-level data (de-identified) - daily – Multiple data elements – Print form Collect data Fax form – Automatic roll-up to Measurement Worksheets
• Measurement Worksheets – Aggregate data - monthly – Numerator and Denominator
Worksheets vs Data Collection Forms
![Page 57: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/57.jpg)
PS Metrics can be used to support: • Small and Large Scale Improvement Initiatives
• Roll Up or Drill Down Reports [e.g. Unit Site Program Corporation Region Province Node National]
• Produce automated run charts • Reporting for accountability
• Possible to customize indicators to meet provincial, regional and local reporting needs
Potential applications of the system
![Page 58: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/58.jpg)
Completing Audit Form - #1
![Page 59: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/59.jpg)
Completing Audit Form - #1 Virginia Flintoft 416-946-8350, [email protected]
![Page 60: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/60.jpg)
Access to PS Metrics
60
https://psmetrics.utoronto.ca/metrics/login.aspx
https://psmetrics.utoronto.ca/metrics/Login.aspx?language=french
![Page 61: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/61.jpg)
• Fax form in FINE RESOLUTION (setting on fax machine)
• Use Flat-bed Fax Machines – feeder faxes produce lines
• Do not write or stamp on forms except where allowed • Incorrectly Filled HCP Bubbles(pen, pencil, but
Sharpie is best)
Beware of Common Errors!
61
![Page 62: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/62.jpg)
Thank you … Questions?
62
![Page 63: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/63.jpg)
Poll Sondage
![Page 64: Canadian VTE Audit - Information Call](https://reader034.vdocuments.mx/reader034/viewer/2022042713/5471880cb4af9fcd0a8b4bd8/html5/thumbnails/64.jpg)
Thank you!
For any questions, contact:
Virginia Flintoft – 416-946-8350
Artemis Diamantouros– 416-480-6100 x3654 Email: [email protected]